surmount-1 trial tirzepatide obesity without diabetes once weekly for the treatment of in people with type 2 (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 SURMOUNT-1: Tirzepatide Drastically Reduces Weight

And because the body can't keep up with all the shedding that's needed with that extra growth, the skin cells build up on its surface, causing thick patches to appear

Who Is a Good Candidate for Treatment

You should call your doctor if you experience: Palpitations lasting more than a few minutes or occurring frequently Chest pain, pressure, or discomfort Dizziness, fainting, or extreme fatigue Shortness of breath Irregular heartbeats that feel very fast or out of control Your doctor may check your heart health through tests such as an electrocardiogram (ECG), a Holter monitor, or blood tests to check electrolytes and thyroid function

The visit is usually anywhere between 30-60 minutes long based on the patient's history and concerns/questions

These mechanisms are not mutually exclusive, and in practice, dizziness during retatrutide treatment may reflect a combination of contributing factors rather than a single cause

The protein transduction domain is critical for topical application